Alaska Becomes Latest State To Regulate PBMs
Published by Inside Health Policy
This week Alaska became the latest state to require pharmacy benefit managers be licensed. The bill, which passed the legislature via unanimous consent earlier this year, also bans gag clauses and lays out guardrails for PBM audits of pharmacies.
“Big money lobbyists and the insurance companies they work for have fought for nearly a decade to prevent a bill like House Bill 240 from passing. We got this bill across the finish line this session because saving Alaskans money on health care costs is not a partisan issue, it’s an Alaskan issue,” state Rep. David Guttenberg (D) wrote in a press release announcing the signing on Tuesday (Aug. 4).
There are growing calls to regulate PBMs. More than 30 states introduced some form of PBM legislation in 2018, making it by far the most common drug-pricing legislation being pursued in the states.
And state legislators are getting help from national groups who are pushing for lower drug prices. The National Academy for State Health Policy released model PBM legislation in August that includes licensure requirements.
Others say legislation may not even be necessary. Drug pricing advocates recently urged a room of insurance commissioners to tackle drug pricing, including regulating PBMs, without legislation.
Alaska’s law requires PBMs to register as third-party administrators biennially. It does not, however, include a requirement that PBMs “exercise good faith and fair dealing,” like a bill awaiting California Governor Jerry Brown’s (D) signature. — Nicholas Florko (nflorko@iwpnews.com)
Recent Posts
-
LTC pharmacies said this would happen. New data says they were right.
By Donna Shryer // Published July 18, 2026 in McKnight’s Long-Term Care News Long-term care pharmacies predicted a steep reimbursement hit from the Inflation Reduction Act’s Medicare drug pricing changes. Now they say they have the data confirming it. A new analysis of member financial data shows reimbursement for drugs subject to the law’s negotiated […]
-
New Analysis Confirms Drug Pricing Changes Hurt LTC Pharmacies, Reinforces Need for Sustainable Payment Reform
Washington, D.C. (July 16, 2026)— A new analysis of member provided financial data confirms what the Senior Care Pharmacy Coalition (SCPC) has warned: the Inflation Reduction Act’s (IRA) Medicare drug pricing provisions that went into effect in 2026 have significantly reduced reimbursement for long-term care (LTC) pharmacies, threatening their financial sustainability and the benefits of […]
-
LTC Pharmacies Double Down On Call For PBM Contract Negotiation Reform
Lauren Brensel // Inside Health Policy – July 23, 2026 A group representing long-term care pharmacies is reminding policymakers of the negative impacts that result from problematic contract negotiations with pharmacy benefit managers, asking CMS to help alleviate pharmacies’ disputes with the three largest PBMs by embracing a series of reforms. LTC pharmacy services like […]
Stay Connected
Get the latest news and updates on issues impacting the long-term care pharmacy community.